Research Paper Volume 15, Issue 16 pp 7997—8012
HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma
Figure 1. Mutation profile of HYDIN in melanoma. (A) Prevalence of HYDIN mutations across various cancers. (B) Mutation diagram of HYDIN in melanoma. (C) The gene mutation panoramas of the TCGA-SKCM cohort.